BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27716071)

  • 21. Histopathological insights into hair loss in Cronkhite-Canada syndrome: diffuse anagen-telogen conversion precedes clinical hair loss progression.
    Watanabe-Okada E; Inazumi T; Matsukawa H; Ohyama M
    Australas J Dermatol; 2014 May; 55(2):145-8. PubMed ID: 23714002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY; Kim HS; Kang CM; Kim SG; Kim MJ
    Clin Nephrol; 1995 Jun; 43(6):375-81. PubMed ID: 7554521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
    Ladapo TA; Esezobor CI; Lesi FE
    Pan Afr Med J; 2016; 25():258. PubMed ID: 28293374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cyclosporine in the treatment of primary focal-segmental glomerulosclerosis].
    Pavlović S; Djukanović Lj; Sindjić M; Stojković D; Banković-Calić N; Velimirović D
    Srp Arh Celok Lek; 1996; 124 Suppl 1():51-3. PubMed ID: 9102929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of cyclosporine A for steroid-resistant severe Henoch-Schönlein purpura nephritis.
    Ohara S; Kawasaki Y; Miyazaki K; Ono A; Suzuki Y; Suyama K; Hosoya M
    Fukushima J Med Sci; 2013; 59(2):102-7. PubMed ID: 24500387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Successful Steroid-Sparing Approach in Cronkhite-Canada Syndrome.
    Mao EJ; Hyder SM; DeNucci TD; Fine S
    ACG Case Rep J; 2019 Mar; 6(3):1-4. PubMed ID: 31620498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remission of steroid- and CyA-resistant nephrotic syndrome using multiple drug immunosuppression.
    Ulinski T; Perrin L; Guigonis V; Driss F; Deschênes G; Bensman A
    Pediatr Nephrol; 2007 Oct; 22(10):1723-6. PubMed ID: 17636340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cronkhite-Canada syndrome: report of six cases and review of literature.
    Wen XH; Wang L; Wang YX; Qian JM
    World J Gastroenterol; 2014 Jun; 20(23):7518-22. PubMed ID: 24966624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine experience in nephrotic syndrome.
    Phadke K; Ballal S; Maiya V
    Indian Pediatr; 1998 Feb; 35(2):111-6. PubMed ID: 9707852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Endoscopic Characteristics of Chinese Cronkhite-Canada Syndrome Patients: A Retrospective Study of 103 Cases.
    Lu Y; Huang F; Wang Y; Zhou J; Zhao Q; Liu L
    Dig Dis; 2021; 39(5):488-495. PubMed ID: 33440392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cronkhite-Canada Syndrome Successfully Treated by Corticosteroids before Presenting Typical Ectodermal Symptoms.
    Murata K; Sato K; Okada S; Suto D; Otake T; Kohgo Y
    Case Rep Gastroenterol; 2020; 14(3):561-569. PubMed ID: 33250698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cronkhite-Canada syndrome - A Case report.
    Rubio CA; Björk J
    Anticancer Res; 2016 Aug; 36(8):4215-7. PubMed ID: 27466534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cronkhite-Canada Syndrome: A rare Case Report from Nepal.
    Pokharel NR; Shrestha P; Sharma V; Pandey S
    J Nepal Health Res Counc; 2021 Sep; 19(2):417-420. PubMed ID: 34601542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome.
    Griveas I; Visvardis G; Papadopoulou D; Nakopolou L; Karanikas E; Gogos K; Stavianoudakis G
    Artif Organs; 2010 Mar; 34(3):234-7. PubMed ID: 20447050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cronkhite-Canada syndrome diagnosis in the absence of gastrointestinal polyps: a case report.
    De Petris G; Chen L; Pasha SF; Ruff KC
    Int J Surg Pathol; 2013 Dec; 21(6):627-31. PubMed ID: 23515557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive treatment of Cronkhite-Canada syndrome: A case report and literature review.
    Hu H; Wu Y; Zhang Y; Zhang L; Zhang J; Zhang R
    Medicine (Baltimore); 2023 Feb; 102(6):e32714. PubMed ID: 36820546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial.
    Saito T; Iwano M; Matsumoto K; Mitarai T; Yokoyama H; Yorioka N; Nishi S; Yoshimura A; Sato H; Ogahara S; Shuto H; Kataoka Y; Ueda S; Koyama A; Maruyama S; Nangaku M; Imai E; Matsuo S; Tomino Y;
    Clin Exp Nephrol; 2014 Oct; 18(5):784-94. PubMed ID: 24363128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporin in steroid-resistant nephrotic syndrome.
    Adhikari M; Coovadia HM
    S Afr Med J; 1994 Nov; 84(11):753-6. PubMed ID: 7495012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical characteristics of Cronkhite-Canada syndrome in Chinese: meta-analysis of 35 cases].
    Cao XC; Zhou B; Ding JJ; Lian J; Lu N; Wang BM
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3130-2. PubMed ID: 18269873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cronkhite-Canada Syndrome- The first case from Pakistan: a case report.
    Ramzi HT; Zainab Y; Manzoor S; Malik A
    J Pak Med Assoc; 2023 Mar; 73(3):693-696. PubMed ID: 36932786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.